Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease. acbr [Internet]. 2025 Sep. 29 [cited 2026 Sep. 20];9(5):392-5. Available from: https://www.fortunejournals.org/ojs/index.php/acbr/article/view/15136